The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 720.00
Bid: 721.00
Ask: 726.00
Change: 0.00 (0.00%)
Spread: 5.00 (0.693%)
Open: 695.00
High: 736.00
Low: 695.00
Prev. Close: 720.00
DSCV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Third Quarter Trading Update

30 Jan 2020 07:00

RNS Number : 3532B
discoverIE Group plc
30 January 2020
 

For Release

7.00am, 30 January 2020

 

discoverIE Group plc

Third Quarter Trading Update

 

discoverIE Group plc (LSE: DSCV, "discoverIE" or the "Group"), a leading international designer, manufacturer and supplier of customised electronics to industry, today issues a trading update for its third quarter, covering the three months to 31 December 2019.

 

Good trading momentum in our Design & Manufacturing division ("D&M") has continued through the third quarter and the Group is on track to deliver full year earnings in line with our expectations.  

 

In the D&M division, third quarter sales increased1 by 16% CER2, representing 7% organic growth3 in line with the performance in the first half. Growth was driven by sales into our target markets, particularly renewable energy and medical. D&M orders were in line with sales. D&M sales comprised two thirds of Group revenue compared with 63% in the first half and generated over 80% of Group profits. Sens-Tech, which was acquired in October 2019, is performing well and in line with our expectations.

 

The Custom Supply ("CS") division experienced the effect of some short-term customer destocking in December, particularly in general industrial markets in Germany and the UK, which resulted in third quarter sales being down by 10% organically. Orders were ahead of sales in the period, with a book to bill ratio of 1.06, and January sales and orders have returned to the higher levels achieved in the first half of the year.

 

Overall, Group third quarter sales increased by 6% CER (up 3% on a reported basis), level organically with last year and with orders ahead of sales. Year to date Group sales have increased by 8% CER, 7% reported and by 3% organically, driven by the D&M division which has grown by 7% organically.

 

The Group order book at 31 December 2019, of which over 80% is for delivery over the next twelve months, continues to be strong, increasing by 5% CER year-on-year, with the D&M division increasing by 12% CER and the CS division reducing by 7% CER.

 

Group gross margin in the third quarter improved by 1ppt over last year and operating expenses and working capital continued to be tightly managed.

 

The Group has a clear strategy focusing on the target markets of renewable energy, medical, transportation and industrial & connectivity to create sustainable organic growth. This platform, together with a pipeline of further acquisition opportunities, means that the Board is confident of making continued progress.

 

 

For further information, please contact:

 

discoverIE Group plc

 

01483 544 500

 

Nick Jefferies

- Group Chief Executive

 

Simon Gibbins

 

- Group Finance Director

 

 

 

 

Instinctif

 

020 7457 2020

Mark Garraway

 

 

James Gray

 

 

 

 

 

Notes

1. Growth rates refer to the comparable prior year period unless stated.

 

2. Growth rates at constant exchange rates ("CER"). The average sterling rate of exchange against the Euro for the quarter strengthened by 3% compared with the average rate for the same period last year, and by 6% on average against the three Nordic currencies, while being in line with the US dollar rate for last year. Stronger Sterling in the third quarter reduced sales by £3m in Q3 and reduced EBIT by £0.4m.

 

3. Organic growth for the Group is calculated at CER and is shown excluding the first 12 months of acquisitions (Cursor Controls was acquired last financial year on 16 October 2018; Hobart and Positek were both acquired on 15 April 2019 and Sens-Tech was acquired on 16 October 2019).

4. This trading update is based upon unaudited management accounts and has been prepared solely to provide additional information on trading to the shareholders of discoverIE Group plc. It should not be relied on by any other party for other purposes. Certain statements made in this update are forward looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this update. Forward looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

5. The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation, Article 7 of EU Regulation 596/2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Notes to Editors:

 

About discoverIE Group plc

 

discoverIE Group plc is an international group of businesses that designs, manufactures and supplies innovative components for electronic applications.

 

The Group provides application-specific components to original equipment manufacturers ("OEMs") internationally. By designing components that meet customers' unique requirements, which are then manufactured and supplied throughout the life of their production, a high level of repeating revenue is generated with long term customer relationships.

 

By focusing on key markets driven by structural growth and increasing electronic content, namely renewable energy, transportation, medical and industrial & connectivity, the Group aims to achieve organic growth that is well ahead of GDP and to supplement that with targeted complementary acquisitions.

 

The Group employs c.4,500 people and its principal operating units are located in Continental Europe, the UK, China, Sri Lanka, India and North America.

 

The Group is listed on the Main Market of the London Stock Exchange and is in the top quartile of the FTSE Small Cap Index, classified within the Electrical Components and Equipment subsector, and has revenues of over £400m. Over the last five years, revenue and underlying earnings per share have both more than doubled.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAXFNASSEEFA
Date   Source Headline
30th Jun 20206:00 pmRNSHolding(s) in Company
30th Jun 20208:00 amRNSHolding(s) in Company
24th Jun 20207:00 amRNSFinal Results
3rd Jun 20201:24 pmRNSHolding(s) in Company
15th May 20207:00 amRNSYear-end & Covid-19 Trading Update
14th May 20204:05 pmRNSDirector Declaration
21st Apr 20201:00 pmRNSDirector Declaration
14th Apr 202010:19 amRNSHolding(s) in Company
9th Apr 202012:35 pmRNSHolding(s) in Company
7th Apr 20201:45 pmRNSIssue of Equity & Total Voting Rights
20th Mar 20204:42 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSYear End Trading Update
11th Mar 20203:04 pmRNSHolding(s) in Company
11th Mar 20201:49 pmRNSDirector/PDMR transaction notification
19th Feb 20207:03 amRNSDirector Declaration
30th Jan 20207:00 amRNSThird Quarter Trading Update
23rd Jan 20208:59 amRNSHolding(s) in Company
16th Jan 202010:57 amRNSHolding(s) in Company
23rd Dec 20199:26 amRNSHolding(s) in Company
9th Dec 20198:42 amRNSHolding(s) in Company
28th Nov 20197:00 amRNSHalf-year Report
19th Nov 20192:58 pmRNSDirector Declaration
23rd Oct 201910:44 amRNSHolding(s) in Company
23rd Oct 20199:01 amRNSHolding(s) in Company
17th Oct 20191:15 pmRNSResults of Placing
17th Oct 20197:00 amRNSAcquisition & Proposed Placing
10th Oct 20197:00 amRNSTrading Update
2nd Sep 20197:00 amRNSDirector Declaration
25th Jul 20191:38 pmRNSResult of AGM
25th Jul 20197:00 amRNSTrading Update
24th Jul 20199:00 amRNSIssue of Equity
10th Jul 201911:40 amRNSHolding(s) in Company
25th Jun 201911:31 amRNSAnnual Report and Accounts
4th Jun 20197:00 amRNSFinal Results
3rd May 20192:48 pmRNSHolding(s) in Company
1st May 20194:21 pmRNSDirector LTIP Award
30th Apr 20199:00 amRNSDirectorate Change
24th Apr 201911:21 amRNSHolding(s) in Company
18th Apr 201911:57 amRNSDirector/PDMR Shareholding
16th Apr 20191:08 pmRNSDirector Declaration
16th Apr 201911:35 amRNSResults of Placing
16th Apr 20197:01 amRNSAcquisitions & Proposed Placing
16th Apr 20197:00 amRNSTrading Update
18th Mar 20192:52 pmRNSHolding(s) in Company
15th Mar 20197:00 amRNSBoard and Committee Changes
8th Feb 20199:22 amRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSThird Quarter Trading Update
5th Dec 201810:12 amRNSDirector/PDMR Shareholding
4th Dec 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.